By Barr Laboratories Inc. | Last revised: 1 January 2010
Pramipexole dihydrochloride tablets are indicated for the treatment of the signs and symptoms of idiopathic Parkinson’s disease. The effectiveness of pramipexole dihydrochloride tablets was demonstrated in randomized, controlled trials in patients…
By University of Michigan Health System dba MedEquip | Last revised: 1 January 2010
M UNIVERSITY OF MICHIGAN HOSPITALS AND HEALTH SYSTEM. HOME CARE SERVICES. HOMEMED MEDEQUIP MICHIGAN VISITING NURSES MICHIGAN VISITING CARE WHEELCHAIR SEATING SERVICE. 2850 S. INDUSTRIAL HWY SUITE 300 ANN ARBOR MI 48104 LIQUID CAN LABEL. WARNINGS…
By Lupin Pharmaceuticals, Inc | Last revised: 1 January 2010
Stable Coronary Artery Disease. Perindopril erbumine tablets are indicated in patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or non-fatal myocardial infarction. Perindopril erbumine tablets can be used…
By Elan Pharma International LTD | Last revised: 1 January 2010
AMPYRA (dalfampridine) is indicated as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed [see Clinical Studies (14). ]. AMPYRA? (dalfampridine) is a potassium channel…
By H.J. Harkins Company, Inc. | Last revised: 1 January 2010
Lisinopril and hydrochlorothiazide is indicated for the treatment of hypertension. These fixed-dose combinations are not indicated for initial therapy (see DOSAGE AND ADMINISTRATION.). In using lisinopril and hydrochlorothiazide, consideration…